Headache Research Library
What Allodynia Tells us About Migraine: Q&A With David Dodick, MD, FAHS
How three factors associated with allodynia, as outlined by the MAST Study, affect migraine treatment options
OnabotulinumtoxinA as a Treatment for Chronic Migraine
Dr. Carrie Dougherty, Assistant Professor in the Department of Neurology and the Program Director of Headache Medicine Fellowship at MedStar Georgetown University Hospital, recently spoke on onabotulinumtoxinA as a potential treatment for patients with chronic migraine.
AHS Launches Position Statement about Integrating New Migraine Treatments Into Clinical Practice
The American Headache Society’s statement addresses the need for updated guidance on the preventive and acute treatment of migraine
Importance of Headache Education in Medical Training: Q&A With Noah Rosen, MD, FAHS
Dr. Noah Rosen believes that through active mentorship and a standardized approach to headache education, current specialists can help grow the field of headache medicine
Honoring a Pioneer of Headache Medicine
AHS interviews master headache clinician Neil H. Raskin
Barriers to Behavioral Therapy in Headache Management
As a part of my standard treatment approach, I discuss behavioral interventions, mainstream pharmacological treatments and other integrative approaches such as magnesium and riboflavin...
From the Journal: Symptoms of Autonomic Dysfunction Amongst Those with Persistent Post-Traumatic Headache
New research published in Headache® finds that people with persistent post-traumatic headache due to mild traumatic brain injury have greater symptoms of autonomic dysfunction compared to individuals with migraine
Concussion, Migraine and Post-Traumatic Headache
One of the most debilitating symptoms a person can experience following a concussion is post-traumatic headache, says Bert Vargas, MD, an associate professor of neurology and the director of the Sports Neurology and Concussion Program at UT Southwestern Medical Center in Dallas.
Migraine and CBD Oil: Doctor Q&A With Stephen Silberstein, MD, FACP, FAHS
Dr. Stephen Silberstein touches on CBD oil as a potential treatment for migraine and current barriers to its use
Medication Overuse Headache: Q&A With Todd Schwedt, MD, FAHS
Medication overuse is highly prevalent among patients with migraine. Dr. Todd Schwedt defines medication overuse headache and explains how the MOTS Trial will influence treatment recommendations
From the Journal: Unnecessary Neuroimaging for Patients with Presumed Primary Headaches
A new paper published in Headache® shows that neuroimaging is a nonessential diagnostic procedure for patients with presumed primary headache disorder.
The State of Headache Medicine: Q&A With Peter Goadsby, MD, PhD, FAHS
Dr. Peter Goadsby outlines key accomplishments in the field of headache medicine and new treatments that are on the horizon
The Value of an American Headache Society Membership: Q&A with Kathleen Digre, MD, FAHS
Dr. Kathleen Digre outlines the evolution of AHS and how health care professionals can benefit from becoming members
Migraine Subgroups
Award-winning study presented at the Scientific Meeting may allow health care specialists to develop more individualized treatment plans